1. Home
  2. AMBA vs SLNO Comparison

AMBA vs SLNO Comparison

Compare AMBA & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ambarella Inc.

AMBA

Ambarella Inc.

HOLD

Current Price

$71.05

Market Cap

3.1B

Sector

Technology

ML Signal

HOLD

Logo Soleno Therapeutics Inc.

SLNO

Soleno Therapeutics Inc.

HOLD

Current Price

$48.61

Market Cap

2.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMBA
SLNO
Founded
2004
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.1B
2.5B
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
AMBA
SLNO
Price
$71.05
$48.61
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
9
10
Target Price
$97.25
$110.90
AVG Volume (30 Days)
1.2M
1.5M
Earning Date
11-25-2025
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$373,850,000.00
$98,675,000.00
Revenue This Year
$39.65
N/A
Revenue Next Year
$9.86
$155.86
P/E Ratio
N/A
N/A
Revenue Growth
48.08
N/A
52 Week Low
$38.86
$41.50
52 Week High
$96.69
$90.32

Technical Indicators

Market Signals
Indicator
AMBA
SLNO
Relative Strength Index (RSI) 39.15 43.46
Support Level $69.62 $48.60
Resistance Level $73.68 $50.95
Average True Range (ATR) 3.26 2.59
MACD -0.37 0.33
Stochastic Oscillator 20.43 10.82

Price Performance

Historical Comparison
AMBA
SLNO

About AMBA Ambarella Inc.

Ambarella Inc is a developer of semiconductor processing solutions for high-definition video capture, sharing, and display. The firm's solutions are sold to original design manufacturers and original equipment manufacturers to be designed for use in infrastructure broadcast encoders, wearable device cameras, automotive cameras, security cameras, consumer cameras, and industrial and robotic applications. The company's system-on-a-chip designs, based on its proprietary technology platform, are configurable to applications in various end markets. Geographical presence in Taiwan, Asia Pacific, Europe, North America, and the United States. The firm derives the majority of its revenue from Taiwan.

About SLNO Soleno Therapeutics Inc.

Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.

Share on Social Networks: